OBJECTIVE: To determine the predictive value of discharge destination as a surrogate for defining unfavorable outcome at 3- and 12-months poststroke. DESIGN: Analysis of the prospectively collected data from a randomized, placebo-controlled trial in patients with ischemic stroke presenting within 3 hours of symptom onset. SETTING: Post hoc analysis of patients recruited in a clinical trial. PARTICIPANTS: Patients (N=530) discharged alive from the hospital after ischemic stroke. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Positive and negative predictive value and likelihood ratios of discharge destination for unfavorable outcome at 3- and 12-months poststroke defined by a Modified Rankin Scale (MRS) score of 2 to 6, 3 to 6, or 4 to 6. A likelihood ratio indicates how many times more (or less) likely a particular discharge destination is seen in patients with an unfavorable outcome compared with those without unfavorable outcome. RESULTS: The positive predictive value of nursing home and rehabilitation facility discharges was highest for unfavorable outcome defined by an MRS score of 2 to 6 (95%) and rehabilitation facility (89%) at 3-months poststroke, respectively. The positive predictive value of rehabilitation facility/nursing home (90%) was also highest for unfavorable outcomes defined by an MRS score of 2 to 6 compared with those defined by MRS scores of 3 to 6 (79%) and 4 to 6 (57%). The positive likelihood ratio was highest for nursing home discharges (13; 95% confidence interval [CI], 4.1-41) followed by rehabilitation facility discharges for unfavorable outcome defined by an MRS score of 2 to 6 at 3-months poststroke (5.3; 95% CI, 3.5-7.9). The negative likelihood ratio was the highest for home discharge for unfavorable outcome defined by an MRS score of 2 to 6 (4.5; 95% CI, 3.4-6.1). A similar pattern was observed with unfavorable outcome defined using various thresholds at 12 months. CONCLUSIONS: Discharge destination can provide high predictive values and likelihood ratios for death and disability at 3-months poststroke, as defined by an MRS of score of 2 to 6.
RCT Entities:
OBJECTIVE: To determine the predictive value of discharge destination as a surrogate for defining unfavorable outcome at 3- and 12-months poststroke. DESIGN: Analysis of the prospectively collected data from a randomized, placebo-controlled trial in patients with ischemic stroke presenting within 3 hours of symptom onset. SETTING: Post hoc analysis of patients recruited in a clinical trial. PARTICIPANTS: Patients (N=530) discharged alive from the hospital after ischemic stroke. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Positive and negative predictive value and likelihood ratios of discharge destination for unfavorable outcome at 3- and 12-months poststroke defined by a Modified Rankin Scale (MRS) score of 2 to 6, 3 to 6, or 4 to 6. A likelihood ratio indicates how many times more (or less) likely a particular discharge destination is seen in patients with an unfavorable outcome compared with those without unfavorable outcome. RESULTS: The positive predictive value of nursing home and rehabilitation facility discharges was highest for unfavorable outcome defined by an MRS score of 2 to 6 (95%) and rehabilitation facility (89%) at 3-months poststroke, respectively. The positive predictive value of rehabilitation facility/nursing home (90%) was also highest for unfavorable outcomes defined by an MRS score of 2 to 6 compared with those defined by MRS scores of 3 to 6 (79%) and 4 to 6 (57%). The positive likelihood ratio was highest for nursing home discharges (13; 95% confidence interval [CI], 4.1-41) followed by rehabilitation facility discharges for unfavorable outcome defined by an MRS score of 2 to 6 at 3-months poststroke (5.3; 95% CI, 3.5-7.9). The negative likelihood ratio was the highest for home discharge for unfavorable outcome defined by an MRS score of 2 to 6 (4.5; 95% CI, 3.4-6.1). A similar pattern was observed with unfavorable outcome defined using various thresholds at 12 months. CONCLUSIONS: Discharge destination can provide high predictive values and likelihood ratios for death and disability at 3-months poststroke, as defined by an MRS of score of 2 to 6.
Authors: A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera Journal: JAMA Date: 1999-12-01 Impact factor: 56.272
Authors: Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren Journal: Lancet Date: 2007-01-27 Impact factor: 79.321
Authors: Ashfaq Shuaib; Kennedy R Lees; Patrick Lyden; James Grotta; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; Tim Ashwood; Warren W Wasiewski; Ugochi Emeribe Journal: N Engl J Med Date: 2007-08-09 Impact factor: 91.245
Authors: T Rundek; H Mast; A Hartmann; B Boden-Albala; L Lennihan; I F Lin; M C Paik; R L Sacco Journal: Neurology Date: 2000-10-24 Impact factor: 9.910
Authors: Ganesh Asaithambi; Xin Tong; Mary G George; Albert W Tsai; James M Peacock; Russell V Luepker; Kamakshi Lakshminarayan Journal: J Stroke Cerebrovasc Dis Date: 2014-08-23 Impact factor: 2.136
Authors: Santosh B Murthy; Yogesh Moradiya; Jharna Shah; Alexander E Merkler; Halinder S Mangat; Costantino Iadacola; Daniel F Hanley; Hooman Kamel; Wendy C Ziai Journal: Neurocrit Care Date: 2016-10 Impact factor: 3.210
Authors: Ganesh Asaithambi; Malik M Adil; Kavisha M Shah; Lori C Jordan; Adnan I Qureshi Journal: Childs Nerv Syst Date: 2014-04-22 Impact factor: 1.475
Authors: Santosh B Murthy; Alexander E Merkler; Setareh Salehi Omran; Gino Gialdini; Aaron Gusdon; Benjamin Hartley; David Roh; Halinder S Mangat; Costantino Iadecola; Babak B Navi; Hooman Kamel Journal: Neurology Date: 2017-04-19 Impact factor: 9.910
Authors: Sebastian Urday; Lauren A Beslow; Feng Dai; Fan Zhang; Thomas W K Battey; Anastasia Vashkevich; Alison M Ayres; Audrey C Leasure; Magdy H Selim; J Marc Simard; Jonathan Rosand; W Taylor Kimberly; Kevin N Sheth Journal: Crit Care Med Date: 2016-04 Impact factor: 7.598
Authors: Santosh B Murthy; Aditi Shastri; Alexander E Merkler; Daniel F Hanley; Wendy C Ziai; Matthew E Fink; Costantino Iadecola; Hooman Kamel; Babak B Navi Journal: J Stroke Cerebrovasc Dis Date: 2016-08-25 Impact factor: 2.136